Evidence map›Paper›PMID 28219355›Full record

ArticleBMC complementary and alternative medicine2017

Vaccaria hypaphorine alleviates lipopolysaccharide-induced inflammation via inactivation of NFκB and ERK pathways in Raw 264.7 cells.

Haijian Sun, Weiwei Cai, Xu Wang, Yanling Liu, Bao Hou, Xuexue Zhu, Liying Qiu

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Phytochemical Profile and Antioxidant Potential ofAntioxidants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hepatoprotective effects of Niudali (Food science & nutrition · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Protective Effects ofFrontiers in veterinary science · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Haijian SunDepartment of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.
Weiwei CaiDepartment of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.
Xu WangDepartment of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.
Yanling LiuLaboratory of Natural Medicine, School of Pharmaceutical Science, Jiangnan University, Wuxi, Jiangsu, China.
Bao HouDepartment of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.
Xuexue ZhuDepartment of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China.
Liying QiuDepartment of Basic Medicine, Wuxi Medical School, Jiangnan University, Wuxi, Jiangsu, 214122, People's Republic of China. qiulydoc@sina.com.
Jiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActivation of macrophage is involved in many inflammation diseases. Lipopolysaccharide (LPS) is a powerful inflammatory signal contributing to monocytes/macrophages activation associated with increased proinflammatory cytokines expressions. We recently identified that vaccarin was expected to protect endothelial cells from injury. Hypaphorine was abundantly found in vaccaria semen. However, the potential roles and underlying mechanisms of vaccaria hypaphorine on macrophage inflammation have been poorly defined.

methodsThis study was designed to determine the effects of vaccaria hypaphorine on LPS-mediated inflammation in RAW 264.7 cells.

resultsIn this study, we demonstrated that vaccaria hypaphorine dramatically ameliorated LPS-induced nitric oxide (NO) release and productions of proinflammatory cytokines including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, IL-10, monocyte chemoattractant protein 1 (MCP-1) and prostaglandin E2 (PGE

conclusionIt was seen that vaccaria hypaphorine counteracted inflammation via inhibition of ERK or/and NFκB signaling pathways. Collectively, we concluded that vaccaria hypaphorine can be served as an anti-inflammatory candidate.

Indexed as

AnimalsAnti-Inflammatory AgentsBiological TransportCyclooxygenase 2CytokinesHumansI-kappa B KinaseIndolesInflammationInflammation MediatorsLipopolysaccharidesMacrophagesMAP Kinase Signaling SystemMCF-7 CellsMiceNF-kappa BAnti-Inflammatory AgentsCyclooxygenase 2CytokinesI-kappa B KinaseIndolesInflammation MediatorslenticinLipopolysaccharidesNF-kappa BNF-KappaB Inhibitor alphaNitric OxideNitric Oxide Synthase Type IIPlant ExtractsCOX-2ERKHypaphorineInflammationiNOSNFκB

Identifiers

PMID28219355
PMCPMC5319035
OpenAlexW2589169282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.